Brodalumab in the Treatment of Immune-Related Adverse Events | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Brodalumab in the Treatment of Immune-Related Adverse Events	Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Liver Neoplasms, Male Urogenital Diseases, Mouth Neoplasms, Neoplasms by Site, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, brain disorder, breast cancer, breast disorder, breast neoplasm, central nervous system cancer, central nervous system disorder, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, esophageal cancer, esophageal disorder, female reproductive organ cancer, gastric cancer, gastric neoplasm, gonadal disorder, head and neck cancer, intestinal disorder, kidney cancer, kidney disorder, liver cancer, liver disorder, lung cancer, lung disorder, lung neoplasm, male reproductive organ cancer, male reproductive system disorder, malignant colon neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, mouth disorder, neoplasm, nervous system disorder, pancreas disorder, pancreatic neoplasm, prostate cancer, prostate disorder, rectal cancer, rectal disorder, rectal neoplasm, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm, stomach disorder, testicular cancer, testicular disorder, thyroid gland disorder, thyroid tumor, urinary system disorder	Recruiting	Phase 1	2026-05-13		NCT06673329

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Bausch Health Americas, Inc.	23
Brian Henick, MD	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Columbia University Irving Medical Center	New York	United States	234